Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Nurix Therapeutics, Inc. - Common stock (NQ:NRIX)

16.75 +1.45 (+9.48%)
Streaming Delayed Price Updated: 10:01 AM EDT, Jun 11, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Nurix Therapeutics, Inc. - Common stock

< Previous 1 2 3 4 5 Next >
News headline image
Sanofi Expands Rare Immunology Portfolio With Blueprint Buyout ↗
Sanofi will acquire Blueprint Medicines for up to $9.5 billion, gaining Ayvakit and a promising immunology pipeline, including BLU-808 and elenestinib. 
Via Benzinga
News headline image
Breaking Down Nurix Therapeutics: 7 Analysts Share Their Views ↗
 
Via Benzinga
News headline image
Cathie Wood Buys More NVIDIA And AMD Stock As Chinese Tech Giants Stockpile Chips Amid Looming US Export Curbs ↗
On Wednesday, April 23, 2025, Cathie Wood of Ark Invest purchased more stock of AMD and Nvidia amid looming US chip curbs against China. 
Via Benzinga
News headline image
Expert Outlook: Nurix Therapeutics Through The Eyes Of 9 Analysts ↗
 
Via Benzinga
News headline image
Beyond The Numbers: 8 Analysts Discuss Nurix Therapeutics Stock ↗
 
Via Benzinga
News headline image
8 Analysts Have This To Say About Nurix Therapeutics ↗
 
Via Benzinga
News headline image
Decoding 9 Analyst Evaluations For Nurix Therapeutics ↗
 
Via Benzinga
News headline image
The Analyst Verdict: Nurix Therapeutics In The Eyes Of 10 Experts ↗
 
Via Benzinga
News headline image
Cathie Wood's Ark Innovation, Genomic ETFs Celebrate 10 Years: How Annual Returns Stack Up Against S&P 500 ↗
The Ark Innovation and Ark Genomic ETFs turn ten years old. A look at the annual returns and current top holdings. 
Via Benzinga
Topics ETFs Stocks
News headline image
Wells Fargo To Rally Around 16%? Here Are 10 Top Analyst Forecasts For Monday ↗
 
Via Benzinga
News headline image
Boeing, Nurix Therapeutics And 3 Stocks To Watch Heading Into Monday ↗
 
Via Benzinga
News headline image
Unveiling 6 Analyst Insights On Nurix Therapeutics ↗
 
Via Benzinga
News headline image
Analyst Ratings For Nurix Therapeutics ↗
 
Via Benzinga
News headline image
Forecasting The Future: 13 Analyst Projections For Nurix Therapeutics ↗
 
Via Benzinga
News headline image
Analyst Scoreboard: 12 Ratings For Nurix Therapeutics ↗
 
Via Benzinga
News headline image
Expert Outlook: Nurix Therapeutics Through The Eyes Of 14 Analysts ↗
 
Via Benzinga
News headline image
This Amazon Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
 
Via Benzinga
News headline image
Nvidia’s Earnings Loom In The Summer Stock Snooze-Fest ↗
To the casual observer, stocks look to be drifting around on a Lazy River ride, but the truth is, they’re consolidating their recent gains. This is actually bullish price action. 
Via Talk Markets
News headline image
TJX To Rally Over 15%? Here Are 10 Top Analyst Forecasts For Wednesday ↗
 
Via Benzinga
News headline image
Peeling Back The Layers: Exploring Nurix Therapeutics Through Analyst Insights ↗
 
Via Benzinga
News headline image
Key Takeaways From Nurix Therapeutics Analyst Ratings ↗
 
Via Benzinga
News headline image
Here Is What You Missed On Wall Street On Friday ↗
Get caught up quickly on the top news and calls moving stocks with these five Top Five lists. 
Via Talk Markets
News headline image
Stock Market Weekly Review: Nvidia, AI Chip Plays Hit Resistance ↗
The Nasdaq and S&P 500 backed off highs. The Dow regained a key level. 
Via Investor's Business Daily
Topics Artificial Intelligence Stocks
News headline image
Nvidia To Rally Around 53%? Here Are 10 Top Analyst Forecasts For Tuesday ↗
 
Via Benzinga
News headline image
What's Going On With Small-Cap Cancer Focused Nurix Therapeutics On Monday? ↗
Nurix Therapeutics presented updated clinical data for NX-5948, an orally bioavailable BTK degrader, at the EHA Congress. NX-5948 showed promising safety and efficacy in Phase 1a/b trials for... 
Via Benzinga
News headline image
Why Nurix Therapeutics Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket ↗
 
Via Benzinga
News headline image
Biotech Stock Nurix Therapeutics Jumps On Positive Leukemia Treatment Trial ↗
San Francisco-based Nurix Therapeutics reported robust results in an ongoing treatment against a stubborn form of leukemia. 
Via Investor's Business Daily
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗
We have all of the biggest pre-market stock movers that investors are going to want to keep an eye on for Monday morning! 
Via InvestorPlace
News headline image
Why JPMorgan Shares Are Trading Lower By Around 5%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗
Shares of JPMorgan Chase & Co. (NYSE: JPM) fell sharply during Friday’s session following first-quarter earnings. 
Via Benzinga
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.